https://www.selleckchem.com/pr....oducts/Decitabine.ht
6-month follow-up was available in 25 (92.6%) patients. At 6-month follow-up, 12 (48.0%) patients were deceased, and the cumulative primary patency rate was 61.9%. The 6-month primary patency rates of open surgical and endovascular interventions were 66.7% and 55.6% respectively. The limb-salvage rate at both 3- and 6-months was 89.2%. Patients with COVID-19 infections who experienced thrombotic events saw high complication and mortality rates with relatively low patency rates. Patients with COVID-19 infections who experienced thromb
Like
Comment
Share
